Magazine article from our research archive:

FDA Final Regulation on Early-Stage Clinical Drug Development

The U.S. Food and Drug Administration (FDA) on July 18 issued a final regulation designed to make early phase 1 clinical drug development "safe and efficient by enabling a phased approach to complying with current good manufacturing practice (CGMP) statutes and FDA investigational requirements," according to an administration press release. To facilitate this new approach, the regulation exempts most phase 1 investigational drugs from the requirements in 21 Code of Federal Regulations (CFR) part 211, The FDA will continue to exercise oversight of the manufacture of these drugs under its general statutory CGMP authority and through review of investigational new drug (IND) applications. A ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!